当前位置： SCI文献检索 > EUROPEAN JOURNAL OF HEART FAILURE期刊下所有文献 > High prevalence of myocarditis in patients with hypertensive heart disease and cardiac deterioration.

High prevalence of myocarditis in patients with hypertensive heart disease and cardiac deterioration.

Abstract：

AIMS:Structural abnormalities causing cardiac deterioration in hypertensive heart disease (HHD) are poorly understood. The aim of the study was to evaluate left ventricular (LV) myocardial changes in patients with HHD and cardiac failure. METHODS AND RESULTS:Among 1229 patients undergoing an LV or biventricular endomyocardial biopsy because of unexplained LV dysfunction from 2000 to 2010, 45 had HHD. The HHD population had non-invasive assessment of cardiac wall thickness, diameters, and function; endomyocardial samples were processed for histology, immunohistochemistry, and polymerase chain reaction (PCR) for cardiotropic viruses. Mean LV end-diastolic diameter was 63.3 ± 5.9 mm, LV ejection fraction 29.7 ± 7.6%, and maximal wall thickness 12.8 ± 0.9 mm. At histology, hypertrophy with degeneration of cardiomyocytes, increased external/lumen ratio of intramural arterioles, and myocardial fibrosis were observed in 17 patients (38%). In the remaining 28 patients (62%), these histological changes were associated with myocarditis. Myocarditis was present in 40.4% of the cohort without HHD. PCR was negative in HHD without inflammation while it was positive in 10 subjects with myocarditis (enterovirus in 3 cases, adenovirus 4, influenza virus 3). Addition of immunosuppression to supportive therapy in the 18 virus-negative myocarditis subjects was followed at 6 months by significant recovery of LV function in 15 (83%; ejection fraction from 25.3 ± 9.3% to 49.5 ± 9.8%) while LV function improved to a minor extent ( ejection fraction from 25 ± 5.1% to 36 ± 4.4%) in 12 of 27 patients (44%) on supportive treatment alone. CONCLUSION:Myocarditis is a major cause of cardiac deterioration in patients with HHD; its recognition may improve patient treatment and outcome.

journal_name

Eur J Heart Fail

journal_title

European journal of heart failure

authors

Frustaci A,Francone M,Petrosillo N,Chimenti C

doi

10.1093/eurjhf/hfs169

subject

Has Abstract

pub_date

2013-03-01 00:00:00

pages

284-91

issue

3

eissn

1388-9842

issn

1879-0844

pii

hfs169

journal_volume

15

pub_type

杂志文章

相关文献

EUROPEAN JOURNAL OF HEART FAILURE文献大全
  • MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure.

    abstract：AIMS:Differentiation of heart failure with reduced (HFrEF) or preserved (HFpEF) ejection fraction independent of echocardiography is challenging in the community. Diagnostic strategies based on monitoring circulating microRNA (miRNA) levels may prove to be of clinical value in the near future. The aim of this study was...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1002/ejhf.244

    authors： Watson CJ,Gupta SK,O'Connell E,Thum S,Glezeva N,Fendrich J,Gallagher J,Ledwidge M,Grote-Levi L,McDonald K,Thum T

    更新日期：2015-04-01 00:00:00

  • Effect of atrial natriuretic peptide on adiponectin in patients with heart failure.

    abstract：BACKGROUND:The adipocyte-specific cytokine adiponectin, has cardioprotective effects, correlates with endogenous cardiac natriuretic peptides and adipocyte has guanylyl cyclase-A receptors of natriuretic peptides. AIMS:To evaluate the effect of carperitide (atrial natriuretic peptide; ANP) on plasma adiponectin in pat...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.ejheart.2008.02.005

    authors： Tanaka T,Tsutamoto T,Sakai H,Nishiyama K,Fujii M,Yamamoto T,Horie M

    更新日期：2008-04-01 00:00:00

  • Patients supported for over 4 years with left ventricular assist devices.

    abstract：:Ventricular assist device implantation has become an established therapy in adults and children for bridging to heart transplantation or to aid myocardial recovery. Recently, implantation of left ventricular assist devices as definitive therapy has been recognized as a better option than pharmacological treatment in p...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1016/j.ejheart.2006.02.003

    authors： Potapov EV,Jurmann MJ,Drews T,Pasic M,Loebe M,Weng Y,Hetzer R

    更新日期：2006-11-01 00:00:00

  • Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?

    abstract：BACKGROUND:Carvedilol is a beta-blocker with similar affinity for beta1- and beta2 receptors, while bisoprolol has higher beta1 affinity. The respiratory system is characterized by beta2-receptor prevalence. Airway beta receptors regulate bronchial tone and alveolar beta receptors regulate alveolar fluid re-absorption ...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.ejheart.2007.04.006

    authors： Agostoni P,Contini M,Cattadori G,Apostolo A,Sciomer S,Bussotti M,Palermo P,Fiorentini C

    更新日期：2007-08-01 00:00:00

  • Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy.

    abstract：AIMS:Loop diuretics are essential for the treatment of chronic heart failure (CHF) but short-acting diuretics are reported to induce sympathetic nervous system (SNS) activation. This study was performed to compare therapeutic effects of two loop diuretics, long-acting azosemide and short-acting furosemide, using (123)I...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,随机对照试验

    doi：10.1093/eurjhf/hfr054

    authors： Hisatake S,Nanjo S,Fujimoto S,Yamashina S,Yuzawa H,Namiki A,Nakano H,Yamazaki J

    更新日期：2011-08-01 00:00:00

  • Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis.

    abstract：AIMS:We evaluated the applicability and prognostic importance of oral glucose tolerance testing (OGTT) among outpatients with systolic heart failure (SHF). METHODS AND RESULTS:Consecutive patients with SHF and left ventricular ejection fraction (LVEF) ≤ 45% referred to a heart failure clinic (n= 413) were included in ...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1093/eurjhf/hfq216

    authors： Egstrup M,Schou M,Gustafsson I,Kistorp CN,Hildebrandt PR,Tuxen CD

    更新日期：2011-03-01 00:00:00

  • Myostatin activation in patients with advanced heart failure and after mechanical unloading.

    abstract：AIMS:Myostatin inhibits myoblast differentiation/proliferation and may play a role in heart failure (HF) and reverse remodelling after left ventricular assist device (LVAD) support. This study sought to characterize myostatin expression and activation in advanced HF before and after LVAD support. METHODS AND RESULTS:L...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1093/eurjhf/hfq039

    authors： George I,Bish LT,Kamalakkannan G,Petrilli CM,Oz MC,Naka Y,Sweeney HL,Maybaum S

    更新日期：2010-05-01 00:00:00

  • Functional effects of glucose transporters in human ventricular myocardium.

    abstract：AIMS:Insulin-dependent positive inotropic effects (PIE) are partially Ca(2+) independent. This mechanism is potentially glucose dependent. In contrast to most animal species, human myocardium expresses high levels of sodium-glucose-transporter-1 (SGLT-1) mRNA besides the common glucose-transporters-1 and -4 (GLUT1, GLU...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1093/eurjhf/hfp191

    authors： von Lewinski D,Gasser R,Rainer PP,Huber MS,Wilhelm B,Roessl U,Haas T,Wasler A,Grimm M,Bisping E,Pieske B

    更新日期：2010-02-01 00:00:00

  • Influence of cardiac-resynchronization therapy on heart rate and blood pressure variability: 1-year follow-up.

    abstract：BACKGROUND:Several studies have shown that cardiac-resynchronization therapy (CRT) improves haemodynamic function, cardiac symptoms, and heart rate variability (HRV) and reduces the risk of mortality and sudden death in subjects with chronic heart failure (CHF). In subjects with CHF, power spectral values for the low-f...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,随机对照试验

    doi：10.1016/j.ejheart.2006.01.008

    authors： Piccirillo G,Magrì D,di Carlo S,De Laurentis T,Torrini A,Matera S,Magnanti M,Bernardi L,Barillà F,Quaglione R,Ettorre E,Marigliano V

    更新日期：2006-11-01 00:00:00

  • Galectin-3: a novel mediator of heart failure development and progression.

    abstract：:Galectins are a family of soluble beta-galactoside-binding lectins that play many important regulatory roles in inflammation, immunity, and cancer. Recently, a role for galectin-3 in the pathophysiology of heart failure (HF) has been suggested. Numerous studies have demonstrated the up-regulation of galectin-3 in hype...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,评审

    doi：10.1093/eurjhf/hfp097

    authors： de Boer RA,Voors AA,Muntendam P,van Gilst WH,van Veldhuisen DJ

    更新日期：2009-09-01 00:00:00

  • Heart failure and sleep apnoea: to sleep perchance to dream.

    abstract：:Heart failure and sleep apnoea are major health problems with an increasingly recognized association; evidence suggests that sleep apnoea may play a role in the progression of heart failure. However, confounding factors such as obesity, hypertension and coronary heart disease make this relationship uncertain and an in...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,评审

    doi：10.1016/j.ejheart.2005.07.013

    authors： Ferreira S,Winck J,Bettencourt P,Rocha-Goncalves F

    更新日期：2006-05-01 00:00:00

  • Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of patients with acute heart failure.

    abstract：:The TRUE-AHF is a randomized, double-blind, parallel-group, placebo-controlled trial which is evaluating the effects of a 48-h infusion of ularitide (15 ng/kg/min) on the short- and long-term clinical course of patients with acute heart failure. Noteworthy features of the study include the early enrolment of patients ...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,多中心研究

    doi：10.1002/ejhf.698

    authors： Packer M,Holcomb R,Abraham WT,Anker S,Dickstein K,Filippatos G,Krum H,Maggioni AP,McMurray JJV,Mebazaa A,O'Connor C,Peacock F,Ponikowski P,Ruschitzka F,van Veldhuisen DJ,Holzmeister J,TRUE-AHF Investigators and Committees

    更新日期：2017-05-01 00:00:00

  • The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure.

    abstract：BACKGROUND:Approximately one third of patients with chronic heart failure have left bundle branch block (LBBB) on their 12-lead ECG. METHODS AND RESULTS:1418 consecutive patients (average (SD) age 70.5 (10.4) years; 74% male) first seen in a community heart failure clinic between December 2001 and June 2006 had a 12 l...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1016/j.ejheart.2008.05.001

    authors： Clark AL,Goode K,Cleland JG

    更新日期：2008-07-01 00:00:00

  • Increased Rho kinase activity in congestive heart failure.

    abstract：AIMS:Rho kinases (ROCKs) are the best characterized effectors of the small G-protein RhoA, and play a role in enhanced vasoconstriction in animal models of congestive heart failure (CHF). This study examined if ROCK activity is increased in CHF and how it is associated with the outcome in CHF. METHODS AND RESULTS:Pati...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1093/eurjhf/hfs068

    authors： Dong M,Liao JK,Fang F,Lee AP,Yan BP,Liu M,Yu CM

    更新日期：2012-09-01 00:00:00

  • Evaluation of left ventricular function and mitral regurgitation during left ventricular-based pacing in patients with heart failure.

    abstract：BACKGROUND:Beneficial effects of left ventricular (LV)-based pacing on acute hemodynamic parameters were reported in several series, but only a few studies examined the long-term effects of this new pacing procedure. AIMS:To assess long-term effects of permanent LV-based pacing on LV function and mitral regurgitation ...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1016/s1388-9842(01)00145-3

    authors： Etienne Y,Mansourati J,Touiza A,Gilard M,Bertault-Valls V,Guillo P,Boschat J,Blanc JJ

    更新日期：2001-08-01 00:00:00

  • Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study.

    abstract：BACKGROUND:The relationship between quality of life (QoL) and survival have been poorly investigated. The aim of this study was to determine the value of QoL score as a prognostic factor in a prospective cohort of patients with advanced chronic heart failure (CHF). METHODS:QoL assessment was performed with a generic q...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1016/s1388-9842(02)00006-5

    authors： Alla F,Briançon S,Guillemin F,Juillière Y,Mertès PM,Villemot JP,Zannad F,EPICAL Investigators.

    更新日期：2002-06-01 00:00:00

  • Heart failure with normal ejection fraction is uncommon in acute myocardial infarction settings but associated with poor outcomes: a study of 91,360 patients admitted with index myocardial infarction between 1998 and 2010.

    abstract：AIM:Data are scant on the incidence and prognosis of heart failure (HF) with normal ejection fraction (HFNEF, EF >49%) in an acute myocardial infarction (AMI) setting. The aim of this study was to examine incidence and predictors of HFNEF during an index acute myocardial infarction (AMI) and its subsequent associations...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1002/ejhf.416

    authors： Desta L,Jernberg T,Spaak J,Hofman-Bang C,Persson H

    更新日期：2016-01-01 00:00:00

  • Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?

    abstract：:Patients with heart failure (HF) are at an increased risk of stroke, sudden death and venous thromboembolism, which are all linked to thrombus formation (thrombogenesis). The present 'viewpoint' article will discuss how the prothrombotic state in HF may be perpetuated by a chronic inflammatory state that is maladaptiv...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,评审

    doi：10.1016/j.ejheart.2006.05.009

    authors： Chong AY,Lip GY

    更新日期：2007-02-01 00:00:00

  • Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial.

    abstract：AIMS:Growth differentiation factor-15 (GDF-15) is associated with adverse prognosis in cardiovascular (CV) and non-CV diseases. We evaluated the association of GDF-15 with CV and non-CV outcomes in the PARADIGM-HF trial. METHODS AND RESULTS:In 1935 patients with heart failure and reduced ejection fraction (HFrEF) in P...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1002/ejhf.1301

    authors： Bouabdallaoui N,Claggett B,Zile MR,McMurray JJV,O'Meara E,Packer M,Prescott MF,Swedberg K,Solomon SD,Rouleau JL,PARADIGM-HF Investigators and Committees.

    更新日期：2018-12-01 00:00:00

  • Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential.

    abstract：:Myocardial fibrosis is the result of excessive fibrillar collagen synthesis and deposition without reciprocally balanced degradation. It causes cardiac dysfunction, arrhythmias, and ischaemia, and thereby determines the clinical course and outcome of cardiac patients even when adequately treated. Therefore, further re...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,评审

    doi：10.1002/ejhf.312

    authors： Heymans S,González A,Pizard A,Papageorgiou AP,López-Andrés N,Jaisser F,Thum T,Zannad F,Díez J

    更新日期：2015-08-01 00:00:00

  • Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients.

    abstract：BACKGROUND:Recent advances in pharmacological and pacemaker-based treatments for heart failure (HF) have brought about significant improvements in left ventricular function. AIMS:To identify the proportion of treated systolic HF patients in whom left ventricular systolic function improves and/or returns to normal. ME...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1016/j.ejheart.2007.10.001

    authors： Murphy NF,O'Loughlin C,Ledwidge M,McCaffrey D,McDonald K

    更新日期：2007-12-01 00:00:00

  • Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation.

    abstract：AIM:The exercise Doppler echocardiographic stress test can be of interest in the management of asymptomatic patients with primary mitral regurgitation (MR). The resting brain natriuretic peptide (BNP) level is a good surrogate marker of the consequences of MR and is a powerful predictor of outcome. The incremental prog...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1093/eurjhf/hfs114

    authors： Magne J,Mahjoub H,Pibarot P,Pirlet C,Pierard LA,Lancellotti P

    更新日期：2012-11-01 00:00:00

  • Relation of atrial natriuretic peptides to left ventricular systolic and diastolic function in heart failure.

    abstract：BACKGROUND:Plasma concentrations of atrial natriuretic peptides are correlated with atrial pressures, as are left ventricular ejection fraction and left ventricular filling abnormalities. AIMS:This study investigated the relation of atrial natriuretic peptides to both left ventricular systolic and diastolic function i...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1016/s1388-9842(98)00005-1

    authors： Wijbenga AA,Balk AH,Jonkman FA,Boomsma F,Simoons ML,Man in t Veld AJ

    更新日期：1999-03-01 00:00:00

  • Comparison of myocardial deformation and velocity dyssynchrony for identification of responders to cardiac resynchronization therapy.

    abstract：AIMS:It is unclear whether myocardial velocity or deformation indices of dyssynchrony are better at predicting response to cardiac resynchronization therapy (CRT). Therefore, two indices of left ventricular (LV) dyssynchrony based on myocardial velocity and deformation were compared to predict success of CRT. METHODS ...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,多中心研究

    doi：10.1093/eurjhf/hfp032

    authors： Mele D,Toselli T,Capasso F,Stabile G,Piacenti M,Piepoli M,Giatti S,Klersy C,Sallusti L,Ferrari R

    更新日期：2009-04-01 00:00:00

  • A rationale for early extracorporeal membrane oxygenation in patients with postinfarction ventricular septal rupture complicated by cardiogenic shock.

    abstract：AIMS:Ventricular septal rupture (VSR) became a rare mechanical complication of myocardial infarction in the era of percutaneous coronary interventions but is associated with extreme mortality in patients who present with cardiogenic shock (CS). Promising outcomes have been reported with the use of circulatory support a...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1002/ejhf.852

    authors： Rob D,Špunda R,Lindner J,Rohn V,Kunstýř J,Balík M,Rulíšek J,Kopecký P,Lipš M,Šmíd O,Kovárník T,Mlejnský F,Linhart A,Bělohlávek J

    更新日期：2017-05-01 00:00:00

  • Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failur

    abstract：BACKGROUND:Coronary artery disease (CAD) is frequent among patients hospitalized with acute heart failure syndromes (AHFS). AIMS:To describe the influence of coronary revascularization status on survival in patients with AHFS. METHODS AND RESULTS:OPTIMIZE-HF enrolled 48,612 patients with AHFS from 259 U.S. hospitals....

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1016/j.ejheart.2008.09.009

    authors： Rossi JS,Flaherty JD,Fonarow GC,Nunez E,Gattis Stough W,Abraham WT,Albert NM,Greenberg BH,O'Connor CM,Yancy CW,Young JB,Davidson CJ,Gheorghiade M

    更新日期：2008-12-01 00:00:00

  • The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis.

    abstract：AIMS:Heart failure (HF) with normal or preserved left ventricular (LV) ejection fraction (HFPEF) has been reported to be associated with similar outcome as HF with reduced EF (HFREF) in registry-based and epidemiological analyses, but many of these studies excluded patients who did not have EF measurements. Conversely,...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,meta分析

    doi：10.1093/eurjhf/hfp103

    authors： Somaratne JB,Berry C,McMurray JJ,Poppe KK,Doughty RN,Whalley GA

    更新日期：2009-09-01 00:00:00

  • Home telemonitoring in heart failure patients: the HHH study (Home or Hospital in Heart Failure).

    abstract：AIMS:The Home or Hospital in Heart failure (HHH) study was a European Community-funded, multinational, randomized controlled clinical trial, conducted in the UK, Poland, and Italy, to assess the feasibility of a new system of home telemonitoring (HT). The HT system was used to monitor clinical and physiological paramet...

    journal_title：European journal of heart failure

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1093/eurjhf/hfp022

    authors： Mortara A,Pinna GD,Johnson P,Maestri R,Capomolla S,La Rovere MT,Ponikowski P,Tavazzi L,Sleight P,HHH Investigators.

    更新日期：2009-03-01 00:00:00

  • Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics.

    abstract：AIMS:Acute heart failure is a high mortality disease and its pathophysiology is not completely understood. Dipeptidyl peptidase 3 (DPP3) is a cytosolic enzyme involved in angiotensin II and enkephalins cleavage. The aim of this study was to investigate the association of circulating DPP3 (cDPP3) levels and mortality in...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1002/ejhf.1601

    authors： Deniau B,Rehfeld L,Santos K,Dienelt A,Azibani F,Sadoune M,Kounde PR,Samuel JL,Tolpannen H,Lassus J,Harjola VP,Vodovar N,Bergmann A,Hartmann O,Mebazaa A,Blet A

    更新日期：2020-02-01 00:00:00

  • Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects.

    abstract：BACKGROUND:Primary desminopathies are caused by desmin gene [DES (MIM*125660)] mutations. The clinical spectrum includes pure myopathies, cardiomuscular diseases and cardiomyopathies. Patients with restrictive cardiomyopathy (RCM) plus atrioventricular block (AVB) due to DES defects are frequently unrecognized unless d...

    journal_title：European journal of heart failure

    pub_type： 杂志文章

    doi：10.1016/j.ejheart.2005.11.003

    authors： Arbustini E,Pasotti M,Pilotto A,Pellegrini C,Grasso M,Previtali S,Repetto A,Bellini O,Azan G,Scaffino M,Campana C,Piccolo G,Viganò M,Tavazzi L

    更新日期：2006-08-01 00:00:00